Focus Financial Network 13F: Adds $731K to LLY Stake
Focus Financial Network increased its holdings in Eli Lilly by 9% in the latest quarter.
Reviewed by automated data checks against the source filing. How we make and check alerts
Focus Financial Network added 632 shares to its stake in Eli Lilly and Company ($LLY), a 9.01% increase, according to a 13F filing with the SEC dated October 14, 2026. It reported 7,646 shares worth $8.85 million at the end of the quarter.
Since the filing, $LLY is up 4.0% to date (from the $1,208.74 close on Oct 14, 2026).
Find the original: Focus Financial Network 13F filings on SEC EDGAR
LLY
Eli Lilly and Company
Key Points
- Focus Financial Network increased its stake in Eli Lilly by 632 shares, bringing its total to 7,646 shares valued at $8.85 million.
- Eli Lilly has a market cap of about $1.04 trillion and a P/E ratio of 39.16, with shares trading between $712.05 and $1,292.65 over the past year.
- The company offers a 0.6% dividend yield and is expected to report earnings on October 29, 2026.
Get $LLY trade alerts by text
We text you when insiders, Congress or big funds trade $LLY. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Eli Lilly and Company alert may contain errors. Disclosures
Focus Financial Network boosted its holdings in Eli Lilly and Company (NYSE:LLY) by 632 shares, according to the latest Form 13F filing with the SEC. This increase brings the firm's total stake to 7,646 shares, valued at approximately $8.85 million, reflecting a 9% increase from the previous quarter.
Focus Financial Network vs. the S&P 500
Hypothetical returns from Focus Financial Network's disclosed trades, not real profit or advice. How we model this.
What Changed in Focus Financial Network's Eli Lilly Position
Focus Financial Network added 632 shares to its position in Eli Lilly, growing its holdings by 9% from 7,014 shares to 7,646 shares. The value of these shares is reported to be about $8.85 million as of the reporting period.
Eli Lilly and Company Stock Up 3.8%
As of Friday, Eli Lilly's stock traded near its previous close of $1,152.93. The company boasts a market cap of approximately $1.04 trillion and trades with a P/E ratio of 39.16 and a forward P/E of 24.60. Eli Lilly's stock has seen a 52-week range from $712.05 to $1,292.65. The 50-day moving average is $1,176.89, and the 200-day moving average stands at $1,066.94. The company's current ratio is 1.36, with a quick ratio of 0.68 and a debt-to-equity ratio of 162.07.
Recent Earnings
Eli Lilly reported revenue of $79.67 billion, with a revenue growth rate of 47.7%. The company's net margin is 33.53%, and its return on equity is 102.29%. The next earnings report is expected on October 29, 2026.
Dividend
Eli Lilly offers an annual dividend rate of $6.92, yielding 0.6%. The dividend payout ratio is 21.69%.
About Eli Lilly and Company
Eli Lilly and Company, headquartered in Indianapolis, Indiana, is a major player in the healthcare sector, specifically in drug manufacturing. The company develops and markets pharmaceutical products worldwide, including treatments for diabetes, cancer, and neurological disorders. Led by CEO David A. Ricks, Eli Lilly employs around 50,000 people.
Bottom Line
Focus Financial Network's increased stake in Eli Lilly indicates its confidence in the pharmaceutical giant's prospects. Investors closely monitor such filings for insights into institutional investment trends. It's important to note that 13F filings are backward-looking and may not reflect the current position of the investor.
Related Filing Alerts
Source: Focus Financial Network's 13F filing on $LLY (Oct 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Focus Financial Network 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts